Novavax CEO Stanley Erck's 2011 pay jumps 50% to $1.4M
Novavax reports 2011 executive compensation
By ExecPay News
Published: April 30, 2012
Novavax reported fiscal year 2011 executive compensation information on April 30, 2012.
In 2011, seven Novavax executives received on average a compensation package of $696K, a 9% decrease compared to previous year.
Average pay of disclosed executives at Novavax
Stanley C. Erck, Chief Executive Officer, received $1.4M in total, which increased by 50% compared to 2010. 64% of Erck's compensation, or $906K, was in option awards. Erck also received $139K in non-equity incentive plan, $370K in salary, as well as $1.2K in other compensation.
Rahul Singhvi, Sc.D, Chief Executive Officer, received a compensation package of $1.2M, which increased by 26% compared to previous year. 61% of the compensation package, or $761K, was in other compensation.
Frederick W. Driscoll, Chief Financial Officer, earned $576K in 2011, a 24% increase compared to previous year.
Gregory M. Glenn, Chief Medical Officer, received $543K in 2011, which decreases by 40% compared to 2010.
Russell P. Wilson, SVP, Business Development, earned $389K in 2011.
John J. Trizzino, Former SVP, Business Development, received $369K in 2011, which decreases by 30% compared to 2010.
Timothy J. Hahn, SVP, Manufacturing and Process Development, earned $339K in 2011.
Related executives
Rahul ScD
Novavax
Chief Executive Officer
John Trizzino
Novavax
Chief Financial Officer
Stanley Erck
Novavax
Chief Executive Officer
Frederick Driscoll
Novavax
Chief Financial Officer
Gregory Glenn
Novavax
President, Research and Development
Timothy Hahn
Novavax
SVP, Manufacturing and Process Development
Russell Wilson
Novavax
SVP, Business Development
You may also like
Source: SEC filing on April 30, 2012.